<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">G3 (Bethesda)</journal-id><journal-id journal-id-type="iso-abbrev">Genetics</journal-id><journal-id journal-id-type="hwp">G3: Genes, Genomes, Genetics</journal-id><journal-id journal-id-type="pmc">G3: Genes, Genomes, Genetics</journal-id><journal-id journal-id-type="publisher-id">G3: Genes, Genomes, Genetics</journal-id><journal-title-group><journal-title>G3: Genes|Genomes|Genetics</journal-title></journal-title-group><issn pub-type="epub">2160-1836</issn><publisher><publisher-name>Genetics Society of America</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7467003</article-id><article-id pub-id-type="publisher-id">GGG_401554</article-id><article-id pub-id-type="doi">10.1534/g3.120.401554</article-id><article-categories><subj-group subj-group-type="heading"><subject>Investigations</subject></subj-group></article-categories><title-group><article-title>A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Dae-Kyum</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref><xref ref-type="author-notes" rid="afn2"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Knapp</surname><given-names>Jennifer J.</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref><xref ref-type="author-notes" rid="afn2"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3554-0464</contrib-id><name><surname>Kuang</surname><given-names>Da</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref><xref ref-type="author-notes" rid="afn2"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chawla</surname><given-names>Aditya</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cassonnet</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff4"><sup>&#x000a7;</sup></xref><xref ref-type="aff" rid="aff5">**</xref><xref ref-type="aff" rid="aff6"><sup>&#x02020;&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Hunsang</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sheykhkarimli</surname><given-names>Dayag</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Samavarchi-Tehrani</surname><given-names>Payman</given-names></name><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abdouni</surname><given-names>Hala</given-names></name><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rayhan</surname><given-names>Ashyad</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Roujia</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pogoutse</surname><given-names>Oxana</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Coyaud</surname><given-names>&#x000c9;tienne</given-names></name><xref ref-type="aff" rid="aff7"><sup>&#x02021;&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>van der Werf</surname><given-names>Sylvie</given-names></name><xref ref-type="aff" rid="aff4"><sup>&#x000a7;</sup></xref><xref ref-type="aff" rid="aff5">**</xref><xref ref-type="aff" rid="aff6"><sup>&#x02020;&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Demeret</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="aff4"><sup>&#x000a7;</sup></xref><xref ref-type="aff" rid="aff5">**</xref><xref ref-type="aff" rid="aff6"><sup>&#x02020;&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gingras</surname><given-names>Anne-Claude</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Taipale</surname><given-names>Mikko</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff8"><sup>&#x000a7;&#x000a7;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Raught</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="aff9">***</xref></contrib><contrib contrib-type="author"><name><surname>Jacob</surname><given-names>Yves</given-names></name><xref ref-type="aff" rid="aff4"><sup>&#x000a7;</sup></xref><xref ref-type="aff" rid="aff5">**</xref><xref ref-type="aff" rid="aff6"><sup>&#x02020;&#x02020;</sup></xref><xref ref-type="corresp" rid="cor1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Roth</surname><given-names>Frederick P.</given-names></name><xref ref-type="aff" rid="aff1">*</xref><xref ref-type="aff" rid="aff2"><sup>&#x02020;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x02021;</sup></xref><xref ref-type="aff" rid="aff10"><sup>&#x02020;&#x02020;&#x02020;</sup></xref><xref ref-type="corresp" rid="cor1"><sup>2</sup></xref></contrib><aff id="aff1"><label>*</label>Donnelly Centre, University of Toronto, Toronto, Ontario, Canada</aff><aff id="aff2"><label>&#x02020;</label>Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada</aff><aff id="aff3"><label>&#x02021;</label>Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada</aff><aff id="aff4"><label>&#x000a7;</label>Unit&#x000e9; de G&#x000e9;n&#x000e9;tique Mol&#x000e9;culaire des Virus &#x000e0; ARN, D&#x000e9;partement Virologie, Institut Pasteur, Paris, France</aff><aff id="aff5"><label>**</label>UMR3569, Centre National de la Recherche Scientifique, Paris, France</aff><aff id="aff6"><label>&#x02020;&#x02020;</label>Universit&#x000e9; de Paris, Paris, France</aff><aff id="aff7"><label>&#x02021;&#x02021;</label>Univ. Lille, Inserm, CHU Lille, U1192 - Prot&#x000e9;omique R&#x000e9;ponse Inflammatoire Spectrom&#x000e9;trie de Masse - PRISM, F-59000 Lille, France</aff><aff id="aff8"><label>&#x000a7;&#x000a7;</label>Molecular Architecture of Life Program, Canadian Institute for Advanced Research, Toronto, Ontario, Canada</aff><aff id="aff9"><label>***</label>Department of Medical Biophysics, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada</aff><aff id="aff10"><label>&#x02020;&#x02020;&#x02020;</label>Department of Computer Science, University of Toronto, Toronto, Ontario, Canada</aff></contrib-group><author-notes><corresp id="cor1"><label>2</label>Corresponding authors: Yves Jacob. Dept de Virologie- Institut Pasteur&#x02013;28 rue du Dr Roux &#x02013;75724. Phone: (33) 1 45 68 87 53. E-mail: <email>yves.jacob@pasteur.fr</email>. Frederick P. Roth. Donnelly Centre, 160 College Street, Toronto, Ontario, Canada M5S 3E1. Phone: (1) 416-946-5130. E-mail: <email>fritz.roth@utoronto.ca</email>.</corresp><fn id="afn2" fn-type="equal"><label>1</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>10</volume><issue>9</issue><fpage>3399</fpage><lpage>3402</lpage><history><date date-type="received"><day>10</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Kim <italic>et al.</italic></copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="3399.pdf"/><abstract><p>The world is facing a global pandemic of COVID-19 caused by the SARS-CoV-2 coronavirus. Here we describe a collection of codon-optimized coding sequences for SARS-CoV-2 cloned into Gateway-compatible entry vectors, which enable rapid transfer into a variety of expression and tagging vectors. The collection is freely available. We hope that widespread availability of this SARS-CoV-2 resource will enable many subsequent molecular studies to better understand the viral life cycle and how to block it.</p></abstract><kwd-group><kwd>SARS-CoV-2</kwd><kwd>coding sequence collection</kwd><kwd>Gateway-compatible</kwd><kwd>TEV (tobacco etch virus) sequence</kwd></kwd-group><funding-group><award-group id="funding-1"><funding-source><institution-wrap><institution>Canadian Institutes for Health</institution><institution-id institution-id-type="DOI">https://doi.org/10.13039/501100000024</institution-id></institution-wrap></funding-source><award-id>Foundation Grant</award-id></award-group><award-group id="funding-2"><funding-source><institution-wrap><institution>Canada Excellence Research Chairs</institution><institution-id institution-id-type="DOI">https://doi.org/10.13039/501100002784</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-3"><funding-source>Thistledown Foundation</funding-source></award-group><award-group id="funding-4"><funding-source>LabEx Integrative Biology of Emerging Infectious Diseases</funding-source><award-id>10-LABX-0062</award-id></award-group><award-group id="funding-5"><funding-source>Platform for European Preparedness Against (Re-)emerging Epidemics</funding-source><award-id>602525</award-id><award-id>Banting Postdoctoral Fellowship</award-id></award-group><award-group id="funding-6"><funding-source><institution-wrap><institution>Natural Sciences and Engineering Research Council of Canada</institution><institution-id institution-id-type="DOI">https://doi.org/10.13039/501100000038</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-7"><funding-source><institution-wrap><institution>National Research Foundation of Korea</institution><institution-id institution-id-type="DOI">https://doi.org/10.13039/501100003725</institution-id></institution-wrap></funding-source><award-id>2017R1A6A3A03004385</award-id></award-group></funding-group><counts><fig-count count="0"/><table-count count="1"/><equation-count count="0"/><ref-count count="26"/><page-count count="4"/></counts></article-meta></front><body><p>A global pandemic of the coronavirus disease COVID-19, a severe respiratory illness caused by a novel virus from the family <italic>Coronaviridae</italic> (SARS-CoV-2), has infected millions and caused hundreds of thousands of deaths (<xref rid="bib23" ref-type="bibr">World Health Organization 2020a</xref>). COVID-19 manifestation in patients can range from a lack of symptoms to severe pneumonia and death (<xref rid="bib12" ref-type="bibr">Huang <italic>et al.</italic> 2020</xref>). Person-to-person spread through respiratory droplets has been identified as a major source of transmission of the virus (<xref rid="bib26" ref-type="bibr">Yu <italic>et al.</italic> 2020</xref>). Various measures, from social distancing to nationwide lockdowns, have been imposed to contain and control the transmission of SARS-CoV-2 (<xref rid="bib6" ref-type="bibr">Cohen and Kupferschmidt 2020</xref>). Despite these measures, the number of confirmed COVID-19 cases has continued to rise (<xref rid="bib23" ref-type="bibr">World Health Organization 2020a</xref>), highlighting the need for an effective vaccine and antiviral agents. Furthermore, the extrapolations concerning the evolution of the pandemic are particularly alarming (<xref rid="bib10" ref-type="bibr">Ferguson <italic>et al.</italic> 2020</xref>). It is therefore of intense and pressing interest to better understand this virus and its interaction with host cells on a molecular level.</p><p>Shortly after the outbreak, the complete genome of two SARS-CoV-2 strains were published (<xref rid="bib4" ref-type="bibr">Chan <italic>et al.</italic> 2020</xref>; <xref rid="bib25" ref-type="bibr">Wu <italic>et al.</italic> 2020</xref>). Using the genome sequence as a reference, Chan <italic>et al.</italic> identified 12 viral open reading frames (ORFs), including one encoding ORF1AB, a large polyprotein which is post-translationally processed into 16 proteins (<xref rid="bib4" ref-type="bibr">Chan <italic>et al.</italic> 2020</xref>). More recently, Wu <italic>et al.</italic> discovered two additional viral ORFs (<italic>ORF9Bwu</italic> and <italic>ORF10wu</italic>) with unclear functions (<xref rid="bib25" ref-type="bibr">Wu <italic>et al.</italic> 2020</xref>). Progress on molecular characterization has been made on several viral proteins (<xref rid="bib21" ref-type="bibr">Walls <italic>et al.</italic> 2020</xref>; <xref rid="bib27" ref-type="bibr">Zhang <italic>et al.</italic> 2020</xref>), providing valuable insights into host-virus interaction, but more research is necessary. The Gateway system offers efficient and high-throughput transfer of the viral coding sequences (CDSs) into a large selection of Gateway-compatible destination vectors used for protein expression in many biological systems, <italic>e.g.</italic>, <italic>Escherichia coli</italic>, <italic>Saccharomyces cerevisiae</italic>, insect, or mammalian cells (<xref rid="bib20" ref-type="bibr">Walhout <italic>et al.</italic> 2000</xref>). Broad availability of a collection of SARS-CoV-2 CDSs has the potential to enable many downstream biochemical and structural studies and thus a better understanding of processes within the viral life cycle, including scalable assays for screening drug candidates that could potentially disrupt these processes.</p><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec id="s2"><title>Synthesis of viral coding sequences</title><p>Based on the published annotation of the genome sequence of the HKU-SZ-005b (GenBank MN975262; <xref rid="bib4" ref-type="bibr">Chan <italic>et al.</italic> 2020</xref>) and Wuhan-Hu-1 (GenBank MN908947; <xref rid="bib25" ref-type="bibr">Wu <italic>et al.</italic> 2020</xref>) isolates of SARS-CoV-2, we requested the synthesis of viral coding sequences (GenScript and Integrated DNA Technologies), including termination codons and <italic>attB</italic> recombination sequences, with optimization of codon usage to reduce GC content and optimize expression in human and insect cells. A start codon was added to <italic>NSP2&#x02013;16</italic> to allow independent transcription and translation, as the endogenous products are derived from <italic>ORF1AB</italic> by post-translational processing. <italic>ORF9Bwu</italic>, an alternative ORF within the <italic>N</italic> gene from SARS-COV-2 (<xref rid="bib25" ref-type="bibr">Wu <italic>et al.</italic> 2020</xref>), was subsequently amplified by polymerase chain reaction (PCR) from the viral <italic>N</italic> gene with primers listed in Table S1.</p></sec><sec id="s3"><title>Generation of Gateway-compatible viral coding sequence clone collections</title><p>Synthesized viral coding sequences were incorporated into Gateway Entry plasmids: either pDONR207 (Invitrogen Cat #12213013) or pDONR223 (<xref rid="bib18" ref-type="bibr">Rual <italic>et al.</italic> 2004</xref>). To enable C-terminal fusion constructs, we also generated an equivalent set of Gateway-compatible clones without termination codons. These clones were made by either PCR-amplifying the whole plasmid with primers that eliminated the stop codon, or by amplifying CDS regions from the first collection, using downstream primers with complementary regions that were internal to each stop codon, and which simultaneously incorporated the flanking sequences necessary for incorporation into a Gateway Entry plasmid [pDONR207, pDONR221 (Invitrogen Cat #12536017) or pDONR223].</p><p>Expression clones with N-terminal fusion tags (<italic>e.g.</italic>, for purification) can be produced simply by preparing the appropriate Gateway-compatible Destination vector. However, to enable the subsequent removal of such N-terminal fusion tags, we generated an additional set of clones containing, at the N-terminus of the ORF, a recognition sequence for nuclear inclusion protease from tobacco etch virus (TEV). TEV sequences were incorporated by amplifying CDS regions from the first collection using forward primers that also provide TEV sequences with the original reverse primers.</p><p>Each SARS-CoV-2 CDS bacterial clone (DH5&#x003b1; <italic>E. coli</italic> strain, NEB Cat# C2987) was isolated from a single colony, and its inserted CDS was confirmed by full-length Sanger sequencing (The Centre for Applied Genomics, Toronto, Canada). All clones with a pDONR221 or pDONR223 backbone were sequenced with M13F and M13R primers. Clones with a pDONR207 backbone were sequenced with customized forward and reverse primers. All primer sequences are available in Table S1.</p></sec><sec sec-type="data-availability" id="s4"><title>Data availability</title><p>Clones are available through Addgene. Table S1 contains all primers used. Table S2 contains detailed descriptions of clones in the collection and links to the clone resource available from Addgene. Supplemental material available at figshare: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.25387/g3.12725096">https://doi.org/10.25387/g3.12725096</ext-link>.</p></sec></sec><sec sec-type="results|discussion" id="s5"><title>Results and Discussion</title><p>A total of 98 clones (<xref rid="t1" ref-type="table">Table 1</xref>) are currently included in the Gateway-compatible collection, covering 28 out of 29 total annotated CDSs in the SARS-CoV-2 genome. <italic>NSP11</italic> was omitted due to the incompatibility of its 36 base pair length with the Gateway cloning system (<xref rid="bib5" ref-type="bibr">Cheo <italic>et al.</italic> 2004</xref>). All 28 of these CDS regions are available as clones with and without termination codons. The &#x02018;no-stop&#x02019; collection was further extended to include six clones encoding different cleaved products of the spike (S) protein &#x02014; &#x0201c;S-fragment&#x0201d; 1&#x02013;6. We also included two CDS variants with in-frame deletions (&#x0201c;S-24nt&#x0201d; and &#x0201c;E-27nt&#x0201d;), one truncated CDS variant (&#x0201c;ORF8B-truncated&#x0201d;), that were each detected by recent viral transcriptome mapping efforts (<xref rid="bib7" ref-type="bibr">Davidson <italic>et al.</italic> 2020</xref>, <xref rid="bib15" ref-type="bibr">Kim <italic>et al.</italic> 2020</xref>) and two missense catalytic variants (<italic>NSP3</italic> C857A and <italic>NSP5</italic> C146A; <xref rid="bib11" ref-type="bibr">Gordon <italic>et al.</italic> 2020</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>The genome-scale SARS-CoV-2 coding sequence clone collection</title></caption><table frame="void" rules="groups"><col width="10.42%" span="1"/><col width="11.69%" span="1"/><col width="38.94%" span="1"/><col width="10.38%" span="1"/><col width="7.41%" span="1"/><col width="10.38%" span="1"/><col width="10.78%" span="1"/><thead><tr><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">Gene Symbol</th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">CDS Name</th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">Putative Function/Domain</th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">AA Length</th><th valign="middle" colspan="3" align="center" scope="colgroup" rowspan="1">Clone Status</th></tr><tr><th valign="middle" colspan="1" align="center" scope="colgroup" rowspan="1">STOP</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">NO STOP</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">TEV</th></tr></thead><tbody><tr><td rowspan="17" valign="middle" align="left" scope="row" colspan="1"><italic>ORF1AB</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">NSP1</td><td valign="middle" align="left" rowspan="1" colspan="1">Suppress antiviral host response</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">180</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP2</td><td valign="middle" align="left" rowspan="1" colspan="1">Unknown</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">639</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP3</td><td valign="middle" align="left" rowspan="1" colspan="1">Putative PL-pro domain</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">1,946</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP3-Cys857Ala</td><td valign="middle" align="left" rowspan="1" colspan="1">Putative PL-pro domain (with Cys857Ala variant)</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">1,946</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP4</td><td valign="middle" align="left" rowspan="1" colspan="1">Complex with NSP3 &#x00026; 6 for DMV (double-membrane vesicle) formation</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">501</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP5</td><td valign="middle" align="left" rowspan="1" colspan="1">3CL-pro domain</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">307</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP5-Cys146Ala</td><td valign="middle" align="left" rowspan="1" colspan="1">3CL-pro domain (with Cys146Ala variant)</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">307</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP6</td><td valign="middle" align="left" rowspan="1" colspan="1">Complex with NSP 3 &#x00026; 4 for DMV formation</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">291</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP7</td><td rowspan="1" valign="middle" align="left" colspan="1">DNA primase subunit</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">84</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP8</td><td valign="middle" align="left" rowspan="1" colspan="1">DNA primase subunit</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">199</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP9</td><td valign="middle" align="left" rowspan="1" colspan="1">RNA/DNA binding activity</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">114</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP10</td><td valign="middle" align="left" rowspan="1" colspan="1">Complex with NSP14: Replication fidelity</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">140</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP12</td><td valign="middle" align="left" rowspan="1" colspan="1">RNA-dependent RNA polymerase</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">919</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP13</td><td valign="middle" align="left" rowspan="1" colspan="1">Helicase</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">602</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP14</td><td valign="middle" align="left" rowspan="1" colspan="1">ExoN: 3&#x02032;-5&#x02032; exonuclease</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">528</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP15</td><td valign="middle" align="left" rowspan="1" colspan="1">XendoU: poly(U)-specific endoribonuclease</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">347</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" colspan="1" align="left" scope="row" rowspan="1">NSP16</td><td valign="middle" align="left" rowspan="1" colspan="1">2&#x02019;-O&#x02019;-MT: 2&#x02019;-O-ribo methyltransferase</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">299</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S</td><td valign="middle" align="left" rowspan="1" colspan="1">Spike glycoprotein trimer that binds to host cell receptors (<italic>e.g.</italic>, ACE2)</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">1,273</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-24nt</td><td valign="middle" align="left" rowspan="1" colspan="1">Spike glycoprotein trimer (minus 8 amino acids)</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">1,265</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-frag1</td><td valign="middle" align="left" rowspan="1" colspan="1">Entire Ectodomain</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">1,213</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-frag2</td><td valign="middle" align="left" rowspan="1" colspan="1">Entire Ectodomain without the signal peptide</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">1,199</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-frag3</td><td valign="middle" align="left" rowspan="1" colspan="1">N-term fragment after the furin cleavage</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">686</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-frag4</td><td valign="middle" align="left" rowspan="1" colspan="1">N-term fragment after the furin cleavage without the signal peptide</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">672</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-frag5</td><td valign="middle" align="left" rowspan="1" colspan="1">C-terminal Ectodomain from the furin cleavage site</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">528</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>S</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">S-frag6</td><td valign="middle" align="left" rowspan="1" colspan="1">C-terminal Ectodomain from the Tmpress 2 priming site</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">399</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF3A</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">3A</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce inflammatory response and apoptosis</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">275</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF3B</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">3B</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce inflammatory response and inhibit the expression of IFN&#x003b2;</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">58</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>E</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">E</td><td valign="middle" align="left" rowspan="1" colspan="1">Envelope protein pentamer</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">75</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>E</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">E-27nt</td><td valign="middle" align="left" rowspan="1" colspan="1">Envelope protein pentamer (minus 9 amino acids)</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">66</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>M</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">M</td><td valign="middle" align="left" rowspan="1" colspan="1">Membrane protein</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">222</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF6</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">6</td><td valign="middle" align="left" rowspan="1" colspan="1">Antagonize STAT1 function and IFN signaling, and induce DNA synthesis</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">61</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF7A</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">7A</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce inflammatory response and apoptosis</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">121</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF7B</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">7B</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce inflammatory response</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">43</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF7B</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">7B-trunc</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce inflammatory response (with N terminus truncated)</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">20</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF8</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">8</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce apoptosis and DNA synthesis</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">121</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>N</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">N</td><td valign="middle" align="left" rowspan="1" colspan="1">Facilitate viral RNA packaging</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">419</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF9B</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">9B</td><td valign="middle" align="left" rowspan="1" colspan="1">Induce apoptosis</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">98</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF9Bwu</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">9Bwu</td><td valign="middle" align="left" rowspan="1" colspan="1">Unknown</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">73</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic>ORF10wu</italic></td><td valign="middle" align="left" rowspan="1" colspan="1">10wu</td><td valign="middle" align="left" rowspan="1" colspan="1">Unknown</td><td valign="middle" align="char" char="." rowspan="1" colspan="1">38</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02713;</td><td valign="middle" align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn><p>&#x02713; indicates that clone is available; NA indicates that the clone was not available the time of this writing.</p></fn></table-wrap-foot></table-wrap><p>Although our collection facilitates tagging of SARS-CoV-2 proteins for various functional studies, certain applications require removal of tags at some stage, for example, after protein purification. Fusion proteins can potentially interfere with the yield, structure, and function of purified proteins, such as during large scale production and crystallography studies (<xref rid="bib1" ref-type="bibr">Booth <italic>et al.</italic> 2018</xref>). To address this we expanded our collection to include clones containing an N-terminal recognition sequence for the nuclear inclusion protease from tobacco etch virus (TEV; <xref rid="bib2" ref-type="bibr">Carrington and Dougherty 1987</xref>; <xref rid="bib3" ref-type="bibr">Carrington and Dougherty 1988</xref>). The TEV sequence is one of the best characterized and widely used endoproteolytic reagents due to its stringent sequence specificity, ease of production, and ability to tolerate a variety of residues at the P1&#x02019; position of its recognition site (<xref rid="bib22" ref-type="bibr">Waugh 2011</xref>). We note that our clones are not expression vectors in and of themselves, and we have not yet assessed the expression of any of our clones after moving to a Gateway Destination expression vector. However, we note that our Gateway-compatible collection allows users the flexibility to conveniently move any of the SARS-CoV-2 ORFs into any Gateway Destination expression vector with any preferred N-terminal or C-terminal fusion.</p><p>To promote open-access dissemination of the collection, all clones have been deposited to the non-profit organization Addgene (<xref rid="bib14" ref-type="bibr">Kamens 2015</xref>), and are freely available from the authors under circumstances where Addgene cannot be used. Table S2 summarizes all CDSs in the collection, together with their nucleotide sequences, nucleotide and amino acid lengths and links for ordering clones.</p><p>We hope that this SARS-CoV-2 CDS-clone collection will be a valuable resource for many applications, including study of how coronaviruses can exploit host cellular processes for the viral replication cycle (<xref rid="bib8" ref-type="bibr">de Wilde <italic>et al.</italic> 2018</xref>), understanding virus-host protein-protein interactions (<xref rid="bib11" ref-type="bibr">Gordon <italic>et al.</italic> 2020</xref>; <xref rid="bib16" ref-type="bibr">Lasso <italic>et al.</italic> 2019</xref>), production of recombinant virus proteins for structural studies (<xref rid="bib9" ref-type="bibr">Edavettal <italic>et al.</italic> 2012</xref>), mapping of protein subcellular localization using N-terminal fluorescent reporters (<xref rid="bib19" ref-type="bibr">Tanz <italic>et al.</italic> 2013</xref>), or development of vaccines or other therapeutics (<xref rid="bib13" ref-type="bibr">Jing <italic>et al.</italic> 2012</xref>; <xref rid="bib17" ref-type="bibr">McDonald <italic>et al.</italic> 2007</xref>).</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by a <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.13039/501100000024">Canadian Institutes for Health</ext-link> Research Foundation Grant (F.P.R.); the <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.13039/501100002784">Canada Excellence Research Chairs</ext-link> Program (F.P.R.); the Thistledown Foundation (B.R., F.P.R. and A.-C.G.); the LabEx Integrative Biology of Emerging Infectious Diseases (10-LABX-0062; Y.J.) and Platform for European Preparedness Against (Re-)emerging Epidemics, EU (602525; Y.J.).</p></ack><fn-group><fn id="fn1"><p>Supplemental material available at figshare: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.25387/g3.12725096">https://doi.org/10.25387/g3.12725096</ext-link>.</p></fn><fn id="fn2"><p>Communicating editor: J. Hesselberth</p></fn></fn-group><ref-list><title>Literature Cited</title><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Booth</surname><given-names>W. T.</given-names></name>, <name name-style="western"><surname>Schlachter</surname><given-names>C. R.</given-names></name>, <name name-style="western"><surname>Pote</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ussin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Mank</surname><given-names>N. J.</given-names></name><etal/></person-group>, <year>2018</year>&#x02003;<article-title>Impact of an N-terminal polyhistidine tag on protein thermal stability.</article-title>
<source>ACS Omega</source>
<volume>3</volume>: <fpage>760</fpage>&#x02013;<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.7b01598</pub-id><pub-id pub-id-type="pmid">29399652</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrington</surname><given-names>J. C.</given-names></name>, and <name name-style="western"><surname>Dougherty</surname><given-names>W. G.</given-names></name></person-group>, <year>1987</year>&#x02003;<article-title>Small nuclear inclusion protein encoded by a plant potyvirus genome is a protease.</article-title>
<source>J. Virol.</source>
<volume>61</volume>: <fpage>2540</fpage>&#x02013;<lpage>2548</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.61.8.2540-2548.1987</pub-id><pub-id pub-id-type="pmid">16789265</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrington</surname><given-names>J. C.</given-names></name>, and <name name-style="western"><surname>Dougherty</surname><given-names>W. G.</given-names></name></person-group>, <year>1988</year>&#x02003;<article-title>A viral cleavage site cassette: Identification of amino acid sequences required for tobacco etch virus polyprotein processing.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>85</volume>: <fpage>3391</fpage>&#x02013;<lpage>3395</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.85.10.3391</pub-id><pub-id pub-id-type="pmid">3285343</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>J. F. W.</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>K. H.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>To</surname><given-names>K. K. W.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.</article-title>
<source>Emerg. Microbes Infect.</source>
<volume>9</volume>: <fpage>221</fpage>&#x02013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheo</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Titus</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Byrd</surname><given-names>D. R.</given-names></name>, <name name-style="western"><surname>Hartley</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Temple</surname><given-names>G. F.</given-names></name><etal/></person-group>, <year>2004</year>&#x02003;<article-title>Concerted assembly and cloning of multiple DNA segments using in vitro site-specific recombination: functional analysis of multi-segment expression clones.</article-title>
<source>Genome Res.</source>
<volume>14</volume>: <fpage>2111</fpage>&#x02013;<lpage>2120</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2512204</pub-id><pub-id pub-id-type="pmid">15489333</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Kupferschmidt</surname><given-names>K.</given-names></name></person-group>, <year>2020</year>&#x02003;<article-title>Countries test tactics in &#x0201c;war&#x0201d; against COVID-19.</article-title>
<source>Science</source>
<volume>367</volume>: <fpage>1287</fpage>&#x02013;<lpage>1288</lpage>. <pub-id pub-id-type="doi">10.1126/science.367.6484.1287</pub-id><pub-id pub-id-type="pmid">32193299</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidson</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>M. K.</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shoemark</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>M. W.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.</article-title>
<source>Genome Med.</source>
<volume>12</volume>: <fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-020-00763-0</pub-id><pub-id pub-id-type="pmid">32723359</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>de Wilde</surname><given-names>A. H.</given-names></name>, <name name-style="western"><surname>Snijder</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Kikkert</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>van Hemert</surname><given-names>M. J.</given-names></name></person-group>, <year>2018</year>&#x02003;<article-title>Host Factors in Coronavirus Replication</article-title>, pp. <fpage>1</fpage>&#x02013;<lpage>42</lpage> in <source>Roles of host gene and non-coding RNA expression in virus Infection</source>, edited by <person-group person-group-type="editor"><name name-style="western"><surname>Tripp</surname><given-names>E.</given-names></name>, and <name name-style="western"><surname>Tompkins</surname><given-names>S.</given-names></name></person-group>
<publisher-name>Springer</publisher-name>, <publisher-loc>Cham</publisher-loc>.</mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edavettal</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>M. J.</given-names></name>, and <name name-style="western"><surname>Swanson</surname><given-names>R. V.</given-names></name></person-group>, <year>2012</year>&#x02003;<article-title>Genetic construct design and recombinant protein expression for structural biology.</article-title>
<source>Methods Mol. Biol.</source>
<volume>841</volume>: <fpage>29</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-520-6_2</pub-id><pub-id pub-id-type="pmid">22222447</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="other">Ferguson, N., D. Laydon, G. G. Nedjati, N. Imai, K. Ainslie <italic>et al.</italic>, 2020&#x02003;Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. doi: 10.25561/77482 (Posted March 16, 2020).<pub-id pub-id-type="doi">10.25561/77482</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>G. M.</given-names></name>, <name name-style="western"><surname>Bouhaddou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Obernier</surname><given-names>K.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.</article-title>
<source>Nature</source>
<volume>583</volume>: <fpage>459</fpage>&#x02013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id><pub-id pub-id-type="pmid">32353859</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.</article-title>
<source>Lancet</source>
<volume>395</volume>: <fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jing</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Haas</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Bruckner</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Dann</surname><given-names>G. C.</given-names></name><etal/></person-group>, <year>2012</year>&#x02003;<article-title>Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.</article-title>
<source>J. Clin. Invest.</source>
<volume>122</volume>: <fpage>654</fpage>&#x02013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1172/JCI60556</pub-id><pub-id pub-id-type="pmid">22214845</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamens</surname><given-names>J.</given-names></name></person-group>, <year>2015</year>&#x02003;<article-title>The Addgene repository: an international nonprofit plasmid and data resource.</article-title>
<source>Nucleic Acids Res.</source>
<volume>43</volume>: <fpage>1152</fpage>&#x02013;<lpage>1157</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku893</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>V. N.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>The architecture of SARS-CoV-2 transcriptome.</article-title>
<source>Cell</source>
<volume>181</volume>: <fpage>914</fpage>&#x02013;<lpage>921.e10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.04.011</pub-id><pub-id pub-id-type="pmid">32330414</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lasso</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mayer</surname><given-names>S. V.</given-names></name>, <name name-style="western"><surname>Winkelmann</surname><given-names>E. R.</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Elliot</surname><given-names>O.</given-names></name><etal/></person-group>, <year>2019</year>&#x02003;<article-title>A structure-informed atlas of human-virus interactions.</article-title>
<source>Cell</source>
<volume>178</volume>: <fpage>1526</fpage>&#x02013;<lpage>1541</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.08.005</pub-id><pub-id pub-id-type="pmid">31474372</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDonald</surname><given-names>W. F.</given-names></name>, <name name-style="western"><surname>Huleatt</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Foellmer</surname><given-names>H. G.</given-names></name>, <name name-style="western"><surname>Hewitt</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J.</given-names></name><etal/></person-group>, <year>2007</year>&#x02003;<article-title>A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.</article-title>
<source>J. Infect. Dis.</source>
<volume>195</volume>: <fpage>1607</fpage>&#x02013;<lpage>1617</lpage>. <pub-id pub-id-type="doi">10.1086/517613</pub-id><pub-id pub-id-type="pmid">17471430</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rual</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Hirozane-Kishikawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bertin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group>, <year>2004</year>&#x02003;<article-title>Human ORFeome version 1.1: a platform for reverse proteomics.</article-title>
<source>Genome Res.</source>
<volume>14</volume>: <fpage>2128</fpage>&#x02013;<lpage>2135</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2973604</pub-id><pub-id pub-id-type="pmid">15489335</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanz</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Castleden</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Small</surname><given-names>I. D.</given-names></name>, and <name name-style="western"><surname>Millar</surname><given-names>A. H.</given-names></name></person-group>, <year>2013</year>&#x02003;<article-title>Fluorescent protein tagging as a tool to define the subcellular distribution of proteins in plants.</article-title>
<source>Front. Plant Sci.</source>
<volume>4</volume>: <fpage>214</fpage>
<pub-id pub-id-type="doi">10.3389/fpls.2013.00214</pub-id><pub-id pub-id-type="pmid">23805149</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walhout</surname><given-names>A. J. M.</given-names></name>, <name name-style="western"><surname>Temple</surname><given-names>G. F.</given-names></name>, <name name-style="western"><surname>Brasch</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Hartley</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Lorson</surname><given-names>M. A.</given-names></name><etal/></person-group>, <year>2000</year>&#x02003;<article-title>Gateway recombinational cloning: Application to the cloning of large numbers of open reading frames or ORFeomes.</article-title>
<source>Methods Enzymol.</source>
<volume>328</volume>: <fpage>575</fpage>&#x02013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1016/S0076-6879(00)28419-X</pub-id><pub-id pub-id-type="pmid">11075367</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walls</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>Y. J.</given-names></name>, <name name-style="western"><surname>Tortorici</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Wall</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>McGuire</surname><given-names>A. T.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.</article-title>
<source>Cell</source>
<volume>181</volume>: <fpage>281</fpage>&#x02013;<lpage>292.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmid">32155444</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waugh</surname><given-names>S. D.</given-names></name></person-group>, <year>2011</year>&#x02003;<article-title>An overview of enzymatic reagents for the removal of affinity tags.</article-title>
<source>Protein Expr. Purif.</source>
<volume>80</volume>: <fpage>283</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.pep.2011.08.005</pub-id><pub-id pub-id-type="pmid">21871965</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>, <year>2020</year><comment>a</comment> &#x02003;COVID-19 situation reports.</mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y. M.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>A new coronavirus associated with human respiratory disease in China.</article-title>
<source>Nature</source>
<volume>579</volume>: <fpage>265</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id><pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, and <name name-style="western"><surname>Han</surname><given-names>Y.</given-names></name></person-group>, <year>2020</year>&#x02003;<article-title>A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period.</article-title>
<source>J. Infect. Dis.</source>
<volume>221</volume>: <fpage>1757</fpage>&#x02013;<lpage>1761</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiaa077</pub-id><pub-id pub-id-type="pmid">32067043</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Curth</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C.</given-names></name><etal/></person-group>, <year>2020</year>&#x02003;<article-title>Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved &#x003b1;-ketoamide inhibitors.</article-title>
<source>Science</source>
<volume>368</volume>: <fpage>409</fpage>&#x02013;<lpage>412</lpage>.<pub-id pub-id-type="pmid">32198291</pub-id></mixed-citation></ref></ref-list></back></article>